Back to search
Platinum-Refractory Fallopian Tube Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Platinum-Refractory Fallopian Tube Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Platinum-Refractory Fallopian Tube Carcinoma trials you may qualify forThis study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participa…
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherap…
This phase I trial tests the safety, side effects, best dose of MUC1-activated T cells in treating patients with ovarian cancer that has come back after a perio…
This phase II trial studies the side effects of ONC201 and paclitaxel and how well they work in treating patients with platinum-resistant epithelial ovarian, fa…
This is an open-label, phase 1/1b, dose-escalation, multicenter and multinational trial evaluating the safety of oncolytic adenovirus TILT-123 in combination wi…
This randomized phase II/III trial studies how well cediranib maleate and olaparib work when given together or separately, and compares them to standard chemoth…